In this expert’s corner video, David Harlan, MD, explains cutting-edge research at UMass Medical School that allows scientists to better understand how the immune system attacks insulin-producing cells in the pancreas, leading to diabetes.
With an $11 million, 5-year program project grant from the National Institute of Allergy and Infectious Diseases, Christopher M. Sassetti, PhD, and an international team of researchers will study the underlying biology of tuberculosis.
A new study co-authored by Guillaume Poirier, PhD, of the Center for Comparative Neuroimaging finds that menthol administered with nicotine alters connectivity patterns in an area of the brain associated with drug reward and addiction and results in behavioral changes.
The 19th annual UMass Medicine Cancer Walk & Run surpassed its fundraising goal, bringing in $560,000 to support cancer research and treatment at UMass Medical School and UMass Memorial Medical Center.
Abraham L. Brass, MD, PhD, received a grant from Gilead Sciences to undertake translational research investigating the interaction between HIV and host cells.
The launch in India of a more effective and economical new treatment for rabies developed by scientists at MassBiologics of UMass Medical School “speaks to the very special nature of the medical school,” Chancellor Michael F. Collins told the Telegram & Gazette.
The pre-eminent international organization for RNA researchers has named Andrei Korostelev, PhD, the recipient of its 2018 Early Career Award, and Erik Sontheimer, PhD, its 2018 Mid-Career Award winner. Both are faculty of the UMMS RNA Therapeutics Institute.
The Serum Institute of India has announced the global launch of Rabishield, a rabies monoclonal antibody developed in partnership with UMass Medical School. Rabishield, a U.S.-patented product, will help close the gaps in rabies prevention and is expected to significantly reduce the rabies mortality rate in India.
Teresita Padilla-Benavides, PhD, has received the 2017 SACNAS Outstanding Research and Professional Mentor award for her demonstrated record of encouraging underrepresented minority students to pursue advanced degrees in a science.
The Center for Tobacco Treatment Research and Training at UMass Medical School has been awarded $1 million from a major tobacco settlement to bring its proven training and research programs, including an app-based behavioral intervention, to Massachusetts communities with higher-than-average adult smoking rates.